Testing a new vaccine for hookworm infection
Planning for Na-GST-1 Hookworm Vaccine Phase 2 CHIM Efficacy Trial
This study is testing a new vaccine for hookworm called Na-GST-1 to see how well it protects healthy volunteers from getting infected after being exposed to hookworm larvae, and it aims to help improve health issues like iron deficiency anemia.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11088462 on NIH RePORTER |
What this research studies
This research aims to plan a clinical trial to evaluate the effectiveness of a new hookworm vaccine called Na-GST-1. The trial will involve healthy volunteers who will receive the vaccine and then be intentionally exposed to hookworm larvae to assess the vaccine's protective effects. The study will utilize a controlled human infection model, which allows researchers to closely monitor the vaccine's impact on hookworm infection and its associated health issues, such as iron deficiency anemia. The vaccine has shown promise in earlier trials, indicating it may be safe and effective.
Who could benefit from this research
Good fit: Ideal candidates for this research are healthy adults who have never been infected with hookworms.
Not a fit: Patients who are already infected with hookworms or have a history of severe allergic reactions to vaccine components may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to an effective vaccine that significantly reduces the incidence of hookworm infections and their health complications.
How similar studies have performed: Previous studies have shown promising results with similar vaccine approaches, indicating potential for success in this trial.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Diemert, David Joseph — George Washington University
- Study coordinator: Diemert, David Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.